On Friday, September 7 we traveled to Los Angeles to attend the sixth annual Stand Up To Cancer telecast. In a special moment during the show, Emily and fellow cancer survivor Nick were given the opportunity to thank the doctors and researchers who treated them.
On August 27, the European Commission announced that Novartis CAR-T cell therapy Kymriah has been approved to treat pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL) and relapsed/refractory diffuse large B-cell lymphoma (DLBCL) in Europe.
On August 10-11, we joined up with UMI Performance Inc. to host a bake sale and 50/50 drawing at the 7th Annual UMI Autocross & Cruise-In event in Clearfield, PA. In just two days, proceeds totaled to $2,500, later matched by Viking Performance to donate a total $5,000 to EWF.
On Saturday, July 21 we had the pleasure of attending the 27th Annual Glenn O. Hawbaker Charity Golf Tournament at Penn State Blue and White Courses in State College, Pa. The Emily Whitehead Foundation was invited to participate as one of eight beneficiaries of this year's tournament.
On Friday, July 13 we hosted our 4th annual "Tee Off for T-Cells" golf tournament at Philipsburg Elks Lodge and Country Club in our hometown of Philipsburg, Pa. This year's event was our most successful yet and raised over $66,000!
It was on this day six years ago that we learned the T-cell therapy had not only saved Emily's life, but also left no evidence of leukemia cells. She was free of cancer, and Kari and I didn’t have to find out what it would be like living without our only daughter.